HALO
Price
$44.71
Change
-$0.68 (-1.50%)
Updated
May 17, 6:59 PM EST
79 days until earnings call
RNA
Price
$29.50
Change
+$0.79 (+2.75%)
Updated
May 17, 6:59 PM EST
79 days until earnings call
Ad is loading...

HALO vs RNA

Header iconHALO vs RNA Comparison
Open Charts HALO vs RNABanner chart's image
Halozyme Therapeutics
Price$44.71
Change-$0.68 (-1.50%)
Volume$582.09K
CapitalizationN/A
Avidity Biosciences
Price$29.50
Change+$0.79 (+2.75%)
Volume$457.95K
CapitalizationN/A
View a ticker or compare two or three
HALO vs RNA Comparison Chart

Loading...

HALODaily Signal changed days agoGain/Loss if shorted
 
Show more...
RNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
HALO vs. RNA commentary
May 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Hold and RNA is a Hold.

COMPARISON
Comparison
May 19, 2024
Stock price -- (HALO: $44.71 vs. RNA: $29.50)
Brand notoriety: HALO and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 114% vs. RNA: 82%
Market capitalization -- HALO: $5.69B vs. RNA: $2.82B
HALO [@Biotechnology] is valued at $5.69B. RNA’s [@Biotechnology] market capitalization is $2.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $586.12B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 2 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • HALO’s FA Score: 2 green, 3 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, HALO is a better buy in the long-term than RNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 6 TA indicator(s) are bullish while RNA’s TA Score has 4 bullish TA indicator(s).

  • HALO’s TA Score: 6 bullish, 4 bearish.
  • RNA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, HALO is a better buy in the short-term than RNA.

Price Growth

HALO (@Biotechnology) experienced а +3.62% price change this week, while RNA (@Biotechnology) price change was +13.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.41%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was +60.72%.

Reported Earning Dates

HALO is expected to report earnings on Aug 06, 2024.

RNA is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+1.41% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for HALO with price predictions.
OPEN
A.I.dvisor published
a Summary for RNA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HALO($5.69B) has a higher market cap than RNA($2.82B). RNA YTD gains are higher at: 225.967 vs. HALO (20.969).
HALORNAHALO / RNA
Capitalization5.69B2.82B202%
EBITDAN/AN/A-
Gain YTD20.969225.9679%
P/E Ratio18.55N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
HALO: Fundamental Ratings
HALO
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
PROFIT vs RISK RATING
1..100
31
SMR RATING
1..100
11
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
82
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HALORNA
RSI
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 12 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
HALODaily Signal changed days agoGain/Loss if shorted
 
Show more...
RNADaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHFTX20.620.02
+0.10%
Invesco Charter R6
IMAYX9.740.01
+0.10%
Delaware Ivy Multi-Asset Income Y
CIMFX24.410.02
+0.08%
American Funds Income Fund of Amer 529F1
MKTRX19.760.01
+0.05%
MainStay Income Builder B
EKSRX5.83-0.01
-0.17%
Allspring Diversified Income Bldr R6